Member of FDA’s expert panel resigns over Alzheimer’s therapy approval:
Following the Food and Drug Administration's polarizing authorization of the Alzheimer's therapy Aduhelm on Monday, a member of an agency advisory committee that recommended against the drug's approval has resigned.
Neurologist Joel Perlmutter of Washington University in St. Louis, a member of the FDA's expert panel for nervous system therapies, told STAT in an email that he had quit the committee on Monday "due to this ruling by the FDA without further discussion with our advisory committee."
The advisory committee, which convened in November, couldn't have been more openly skeptical of the drug, also known as aducanumab. Ten of the 11 panelists found that there was not enough evidence to show it could slow cognitive decline. The 11th voted "uncertain."
(Score: 0) by Anonymous Coward on Saturday June 12 2021, @02:25PM
If only... The same corruption that got this bill passed will get it covered by medicare. So everybody can have their $56,000 sugar-pill.
And you'll be the one paying for it; directly through higher taxes to cover the 'healthcare costs of the needy and elderly' (doesn't that just make you feel all warm and cozy on the inside?), and indirectly through paying more for everything as we continue printing money to no end sending inflation up, up, and away.